Drug Discovery Today

Assessing the impact of current trends in genomics on the future of pharmaceutical R&D
pp. 161-162(2)
Authors: Arlington S.; Peakman T.

New hope for fungal vaccines?
pp. 163-164(2)
Author: Lawrence R.N.

Viral gene therapy for haemophilia
pp. 165-166(2)
Author: Fricker J.

Flower power: fact or fiction?
pp. 166-167(2)
Author: Owens J.

A budding role for the UPR
pp. 167-168(2)
Author: Dorrell S.

News in brief
pp. 169-170(2)
Authors: Owens J.; Lawrence R.N.

People
pp. 171-171(1)
Author: Lawrence

Vincent Lee on integration of drug delivery and discovery - Interviewed by Rebecca N. Lawrence
pp. 172-174(3)
Author: Lee V.H.L.

The optimal fragmentation principle
pp. 175-175(1)
Author: Johnson D.E.

More clinical input required for R&D decision-making?
pp. 175-176(2)
Author: Jain K.K.

Optimizing screening technology: how much to invest? - Reply
pp. 176-177(2)
Author: Glickman J.F.

Nucleic Acids: Structures, Properties and Functions
pp. 178-179(2)
Author: Demidov V.V.

Clinical pharmacogenomics: applications in pharmaceutical R&D
pp. 180-185(6)
Author: Norton R.M.

Developing non-viral DNA delivery systems for cancer and infectious disease
pp. 186-197(12)
Authors: Spack E.G.; Sorgi F.L.

Exploiting human genetic variation in drug discovery and development
pp. 198-205(8)
Author: Jazwinska E.C.

Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 2)
pp. 206-212(7)
Authors: Kusuhara H.; Sugiyama Y.

Monitor: molecules and profiles
pp. 213-216(4)
Author: Walker M.A.

Novel antitumour molecules
pp. 215-216(2)
Author: Westwell A.

Drug delivery
pp. 216-217(2)
Author: Weidner J.